PCI Ventures supports a wide-ranging portfolio of early-stage companies through their UPstart and UPadvisors programs. The ever-expanding portfolio includes companies in life sciences, medical devices, healthcare management, advanced materials, information technology, and robotics. PCIV actively seeks entrepreneurs to lead its companies and investors to provide funding for the new ventures in development.
Advac Therapeutic
Development of vaccines and therapeutics for the treatment of infectious diseases and cancers
Aero2Max
A revolutionary smart training system for high-performance athletes
AgingSense
Wearing physiological sensors to monitor for exacerbations of heart failure
Axonova Medical
Proprietary technology platform allowing stretch growth of axon bundles for use as fully functional grafts to address peripheral and CNS neuropathies.
Calorint
Heat-based technology for wound healing
Carisma Therapeutics
$Cellular immunotherapy for solid tumors.
Carousel Therapeutics
$Carousel Therapeutics is developing a universal CAR-T targeting system for the treatment of relapse and refractory solid tumors.
Cartio
Developing CAR regulatory T cells to treat atherosclerosis and other cardiovascular diseases.
Cerespectus
Catheters using real time anatomic video feedback and fluoroscopic assistance for precise gene therapy delivery and treatment of other disorders of the central nervous system
Chip Diagnostics
$Lab-on-a-chip platform addressing the need for rapid, inexpensive, and highly sensitive diagnostics